MET and non-small cell lung carcinoma: However, dysregulation of hepatocyte growth factor receptor (c-MET) significantly correlates with aggressive proliferation, invasive and pathological motility profiles in several malignancies [11,12], particularly NSCLC, gastrointestinal (GI) cancer and hepatocellular carcinoma (HCC) [13,14,15,16].